NRI.TO - Nuvo Pharmaceuticals Inc.

Toronto - Toronto Delayed Price. Currency in CAD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue19,99817,52327,03920,495
Cost of Revenue8,6388,68612,77411,036
Gross Profit11,3608,83714,2659,459
Operating Expenses
Research Development----
Selling General and Administrative8,5387,0516,6772,645
Non Recurring----
Total Operating Expenses19,16515,73719,45113,681
Operating Income or Loss8331,7867,5886,814
Income from Continuing Operations
Total Other Income/Expenses Net-7,173-204-1791,521
Earnings Before Interest and Taxes8331,7867,5886,814
Interest Expense----
Income Before Tax-6,3401,5827,4098,335
Income Tax Expense-1871-7
Minority Interest----
Net Income From Continuing Ops-6,1531,5817,4098,328
Non-recurring Events
Discontinued Operations---3,180-15,448
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-6,1531,5814,229-7,120
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-6,1531,5814,229-7,120